Literature DB >> 3199415

Differential toxicity of cis and trans isomers of dichlorodiammineplatinum.

G Singh1, J Koropatnick.   

Abstract

Nephrotoxicity is the dose-limiting toxic effect of cis-dichlorodiammineplatinum (cis-platin) in humans. Its stereoisomer transplatin does not have any toxicity at equimolar concentrations, and it also possesses little antitumor activity. In this study, subcellular localization of both the platinum isomers was examined in the liver and kidney of the mouse 24 hours following the drug administration. Levels of the platinum isomers were measured using flameless atomic absorption. The results showed that higher concentrations of the cis isomer were localized in the liver and kidney, while the concentration of the trans isomer was higher in blood. This indicates that trans isomer is sequestered in the central compartment, whereas cis isomer is distributed in the organs. We also measured metallothionein mRNA and protein levels in both liver and kidney following cisdichlorodiammineplatinum and transdichlorodiammine-platinum treatment to distinguish if the differential toxicity of the two stereoisomers could be related to metallothionein induction. We report here that cisplatin was capable of inducing metallothionein expression in mice in vivo and that there is an inverse relationship between metallothionein expression and the pattern of tissue toxicity induced by the drug.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199415     DOI: 10.1002/jbt.2570030308

Source DB:  PubMed          Journal:  J Biochem Toxicol        ISSN: 0887-2082


  5 in total

1.  Radioimmunoassay of metallothionein in rabbit, rat, mouse, Chinese hamster, and human cells.

Authors:  M E Leibrandt; J Koropatnick; J F Harris; M G Cherian
Journal:  Biol Trace Elem Res       Date:  1991-09       Impact factor: 3.738

2.  Differential effects of cisplatin on mouse hepatic and renal mitochondrial DNA.

Authors:  E Maniccia-Bozzo; M B Espiritu; G Singh
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

3.  Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment.

Authors:  G Singh; E Maniccia-Bozzo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.

Authors:  F Courjault; D Leroy; L Coquery; H Toutain
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.

Authors:  Anne M Galea; Vincent Murray
Journal:  Cancer Inform       Date:  2008-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.